Distribution of HPV and cytological diagnosis at different age groups at baseline
| Age group (years) | Cytological diagnosis | HPV infection | HR-HPV infection | Total (%) | |||
| NILM (%) | ≥ASC-US (%) | Non-HR-HPV (%) | HR-HPV (%) | 16/18 (%) | 12OT (%) | ||
| 30–39 | 636 (93.8) | 42 (6.2) | 580 (85.5) | 98 (14.5) | 34 (5.0) | 64 (9.4) | 678 (100.0) |
| 40–49 | 1308 (90.3) | 140 (9.7) | 1266 (87.4) | 182 (12.6) | 63 (4.4) | 119 (8.2) | 1448 (100.0) |
| 50–59 | 720 (78.2) | 201 (21.8) | 767 (83.3) | 154 (16.7) | 45 (4.9) | 109 (11.8) | 921 (100.0) |
| 60–64 | 99 (61.1) | 63 (38.9) | 133 (82.1) | 29 (17.9) | 10 (6.2) | 19 (11.7) | 162 (100.0) |
| Total | 2763 (86.1) | 446 (13.9) | 2746 (85.6) | 463 (14.4) | 152 (4.7) | 311 (9.7) | 3209 (100.0) |
12OT: HPV 16, HPV 18, HPV 31, HPV 33, HPV 35, HPV 39, HPV 45, HPV 51, HPV 52, HPV 56, HPV 58, HPV 59, HPV 66 and HPV 68.
ASC-US, atypical squamous cells of undetermined significance; HPV, human papillomavirus; HR, high-risk; NILM, negative for intraepithelial lesion or malignancy; OT, other HR-HPV genetype.